Torsten Dreier
Career history of Torsten Dreier
Former positions of Torsten Dreier
| Companies | Position | Start | End |
|---|---|---|---|
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | 1994-12-31 | - |
| ARGENX SE | Founder | 2007-12-31 | - |
| Corporate Officer/Principal | 2008-04-30 | - | |
Micromet AG
 Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Corporate Officer/Principal | 1996-12-31 | - |
| ABLYNX | Corporate Officer/Principal | - | - |
Training of Torsten Dreier
| Eberhard Karls Universität Tübingen | Doctorate Degree |
Statistics
International
| Germany | 3 |
| United States | 2 |
| Belgium | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Private companies | 2 |
|---|---|
Micromet AG
Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
- Stock Market
- Insiders
- Torsten Dreier
- Experience
